Juliette Albuisson is an expert in Genetics at Centre Georges François Leclerc (France). Juliette Albuisson has authored 82 publications, the most recent in 2026. SLR score: 171 (community average: 125). How the SLR is computed.

LeadR Profile

Juliette Albuisson Centre Georges François Leclerc France
171 ScienceLeadR Reputation 171
Network Map

Genetics

Subspecialties: Oncology - Gynecology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2005 - 2026

Source: PubMed

Centre Georges François Leclerc

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 82

Citations

Citations: 3 606 1st author: 6 Last author: 6 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
[GFCO national recommendations on the use of liquid biopsy for circulating tumor DNA analysis in oncology].
PMID 42493294 — circulating tumor dna, neoplasms, biopsy, dna, liquid biopsy
Bull Cancer20260
Age-related distribution of homologous recombination deficiency in advanced ovarian carcinoma: a large real-world French cohort.
PMID 42462286 — cells, research design, recombination, genetic, homologous recombination, ovary, neoplasms, aged, recombinational dna repair, ovarian neoplasms, prevalence, therapeutics
Int J Gynecol Cancer20260
Technical recommendations from a large-scale French Delphi consensus: A step toward European harmonization of ctDNA analysis.
PMID 42190398 — research design, neoplasms, biopsy, liquid biopsy
Eur J Cancer20260
Abnormal DNA Methylation Profile Suggests the Extension of the Clinical Spectrum of the SETD2 -Related Disorders to a Syndromic Multiple Tumor Phenotype.
PMID 40104911 — genes, neoplasms, phenotype, dna methylation, dna, intellectual disability, genetics, medical
Am J Med Genet A20252
Digenic Inheritance of Monoallelic MUTYH and POLE Germline Variants in Adrenocortical Carcinoma: Implications for Tumorigenesis and Immunotherapy.
PMID 39900383 — immunotherapy, carcinogenesis, adrenocortical carcinoma, genetics, medical
Clin Genet20250

LeadR Networks

Main global connection map